Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners

TORONTO, June 02, 2020 (GLOBE NEWSWIRE) — Blueberries Medical Corp. (CSE: BBM) (OTC: BBRRF) (FRA: 1OA) (the “Company” or “Blueberries“), a Latin American licensed producer of medicinal cannabis and cannabis-derived products, is pleased to announce that it has officially commenced sales of its proprietary cultivars approved by the Colombian Institute of Agriculture (“ICA”). Blueberries hasContinue reading “Blueberries Commences Commercial Sales of Proprietary Cultivars to Local Partners”